Cytek Biosciences to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Cytek Biosciences (Nasdaq: CTKB) announced investor conference participation and investor meetings in November–December 2025. Key events include UBS Global Healthcare Conference (Palm Beach) with 1x1 meetings on Nov 11, 2025, a Stephens NASH25 fireside chat on Nov 19, 2025 at 9:00 a.m. PT / 12:00 p.m. ET, and a Piper Sandler 37th Annual Healthcare fireside chat on Dec 3, 2025 at 6:00 a.m. PT / 9:00 a.m. ET.

Live and archived webcasts for the Stephens and Piper Sandler presentations will be available on the company investor website at investors.cytekbio.com.

FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences.

• UBS Global Healthcare Conference in Palm Beach, FL
  Participating in investor 1x1 meetings on Tuesday, November 11, 2025

• Stephens NASH25 Investment Conference in Nashville, TN
  Fireside chat on November 19, 2025, at 9:00 a.m. Pacific Time /12:00 p.m. Eastern Time

• Piper Sandler 37^th Annual Healthcare Conference in New York, NY
  Fireside chat on December 3, 2025, at 6:00 a.m. Pacific Time / 9:00 a.m. Eastern Time

Interested parties may access live and archived webcasts of the presentations for the Stephens and Piper Sandler events referenced above on the “Investors” section of the company website at: investors.cytekbio.com.

About Cytek Biosciences, Inc.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP^®) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes: its core FSP instruments, the Cytek Aurora™, Northern Lights™, Cytek Aurora™ CS and Cytek Aurora™ Evo systems; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle™ (ESP™) detection technology; the flow cytometers and imaging products under the Amnis^® and Guava^® brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.

Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use only in China and the European Union).

Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Enhanced Small Particle, ESP, Cytek Orion, Amnis and Guava are trademarks of Cytek Biosciences, Inc.

In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.

Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com

Investor Contact:
Paul Goodson
Head of Investor Relations
Cytek Biosciences
pgoodson@cytekbio.com 

FAQ

When will Cytek Biosciences (CTKB) hold investor meetings at the UBS Global Healthcare Conference?

CTKB will participate in 1x1 investor meetings at the UBS Global Healthcare Conference on November 11, 2025.

What time is the Cytek Biosciences (CTKB) fireside chat at Stephens NASH25 on November 19, 2025?

The CTKB fireside chat at Stephens NASH25 is scheduled for November 19, 2025 at 9:00 a.m. PT / 12:00 p.m. ET.

When is the Cytek Biosciences (CTKB) presentation at the Piper Sandler 37th Annual Healthcare Conference?

CTKB will hold a fireside chat at the Piper Sandler conference on December 3, 2025 at 6:00 a.m. PT / 9:00 a.m. ET.

Where can investors watch Cytek Biosciences (CTKB) conference webcasts

Live and archived webcasts for the Stephens and Piper Sandler events will be available at investors.cytekbio.com.

Will Cytek Biosciences (CTKB) make the UBS conference meetings public?

The announcement notes CTKB will participate in 1x1 meetings at UBS on Nov 11, 2025; no public webcast for UBS was announced.

How can investors get alerts or follow CTKB presentations during these conferences?

Investors can monitor the company investor site investors.cytekbio.com for live webcasts, archived recordings, and potential event notices.